The post Breaking: Bitmine Immersion Bolsters Ethereum Holdings to 3.73M ETH, BMNR Stock Tanks 8% appeared on BitcoinEthereumNews.com. Key Insights: Bitmine Immersion added 96,798 ETH worth $273 million to its Ethereum treasury. Tom Lee-backed firm boosts its total holdings to 3,726,499 ETH. BMNR stock tumbled 8% to $30.44 on Monday. Ethereum price risks falling to $2,500 if bulls fail to rebound the price above $3,000. Bitmine Immersion, the largest Ethereum treasury, has acquired an additional 96,798 ETH worth $273 million. Fundstrat’s Tom Lee-backed firm continues to boost its Ethereum holdings by buying ETH on dips. BMNR stock price fell more than 8% on Monday. Traders sold stock in their portfolio as ETH price tumbled 8% to below $2,800. Bitmine Immersion Adds $293 Million in Ethereum NYSE-listed Bitmine Immersion Technologies disclosed its crypto and cash holdings of $12.1 billion, according to an official announcement on December 1. The company purchased an additional 96,798 ETH for $273 million between November 24-30. Also, the company holds 192 BTC and $882 million in additional cash. It also holds a $36 million stake in Eightco Holdings (ORBS). This makes Bitmine Immersion the second-largest global crypto treasury, behind Michael Saylor’s Strategy. Tom Lee-backed company expanded its total Ethereum holdings to 3,726,499 ETH, accounting for $11.52 billion at an average price of $3,008 per ETH. The total holding is worth nearly $10.43 billion at the current market price. “As we look ahead to December, the Fusaka upgrade, aka Fulu-Osaka, is scheduled for activation on December 3rd and delivers an array of improvements in scalability, enhanced security, and usability,” said Tom Lee. As The Coin Republic reported earlier, BitMine Immersion continued ETH purchases at dips. The firm last added 20,532 ETH worth $63.32 million. BitMine (BMNR) Stock Price Jumps At the time of writing, BMNR stock price was trading more than 8% lower at $30.49 on Monday. The stock closed at 1.88% higher $33.16 on Friday. BitMine stock price jumped 19% last week amid… The post Breaking: Bitmine Immersion Bolsters Ethereum Holdings to 3.73M ETH, BMNR Stock Tanks 8% appeared on BitcoinEthereumNews.com. Key Insights: Bitmine Immersion added 96,798 ETH worth $273 million to its Ethereum treasury. Tom Lee-backed firm boosts its total holdings to 3,726,499 ETH. BMNR stock tumbled 8% to $30.44 on Monday. Ethereum price risks falling to $2,500 if bulls fail to rebound the price above $3,000. Bitmine Immersion, the largest Ethereum treasury, has acquired an additional 96,798 ETH worth $273 million. Fundstrat’s Tom Lee-backed firm continues to boost its Ethereum holdings by buying ETH on dips. BMNR stock price fell more than 8% on Monday. Traders sold stock in their portfolio as ETH price tumbled 8% to below $2,800. Bitmine Immersion Adds $293 Million in Ethereum NYSE-listed Bitmine Immersion Technologies disclosed its crypto and cash holdings of $12.1 billion, according to an official announcement on December 1. The company purchased an additional 96,798 ETH for $273 million between November 24-30. Also, the company holds 192 BTC and $882 million in additional cash. It also holds a $36 million stake in Eightco Holdings (ORBS). This makes Bitmine Immersion the second-largest global crypto treasury, behind Michael Saylor’s Strategy. Tom Lee-backed company expanded its total Ethereum holdings to 3,726,499 ETH, accounting for $11.52 billion at an average price of $3,008 per ETH. The total holding is worth nearly $10.43 billion at the current market price. “As we look ahead to December, the Fusaka upgrade, aka Fulu-Osaka, is scheduled for activation on December 3rd and delivers an array of improvements in scalability, enhanced security, and usability,” said Tom Lee. As The Coin Republic reported earlier, BitMine Immersion continued ETH purchases at dips. The firm last added 20,532 ETH worth $63.32 million. BitMine (BMNR) Stock Price Jumps At the time of writing, BMNR stock price was trading more than 8% lower at $30.49 on Monday. The stock closed at 1.88% higher $33.16 on Friday. BitMine stock price jumped 19% last week amid…

Breaking: Bitmine Immersion Bolsters Ethereum Holdings to 3.73M ETH, BMNR Stock Tanks 8%

Key Insights:

  • Bitmine Immersion added 96,798 ETH worth $273 million to its Ethereum treasury.
  • Tom Lee-backed firm boosts its total holdings to 3,726,499 ETH.
  • BMNR stock tumbled 8% to $30.44 on Monday.
  • Ethereum price risks falling to $2,500 if bulls fail to rebound the price above $3,000.

Bitmine Immersion, the largest Ethereum treasury, has acquired an additional 96,798 ETH worth $273 million. Fundstrat’s Tom Lee-backed firm continues to boost its Ethereum holdings by buying ETH on dips.

BMNR stock price fell more than 8% on Monday. Traders sold stock in their portfolio as ETH price tumbled 8% to below $2,800.

Bitmine Immersion Adds $293 Million in Ethereum

NYSE-listed Bitmine Immersion Technologies disclosed its crypto and cash holdings of $12.1 billion, according to an official announcement on December 1.

The company purchased an additional 96,798 ETH for $273 million between November 24-30. Also, the company holds 192 BTC and $882 million in additional cash.

It also holds a $36 million stake in Eightco Holdings (ORBS). This makes Bitmine Immersion the second-largest global crypto treasury, behind Michael Saylor’s Strategy.

Tom Lee-backed company expanded its total Ethereum holdings to 3,726,499 ETH, accounting for $11.52 billion at an average price of $3,008 per ETH. The total holding is worth nearly $10.43 billion at the current market price.

“As we look ahead to December, the Fusaka upgrade, aka Fulu-Osaka, is scheduled for activation on December 3rd and delivers an array of improvements in scalability, enhanced security, and usability,” said Tom Lee.

As The Coin Republic reported earlier, BitMine Immersion continued ETH purchases at dips. The firm last added 20,532 ETH worth $63.32 million.

BitMine (BMNR) Stock Price Jumps

At the time of writing, BMNR stock price was trading more than 8% lower at $30.49 on Monday. The stock closed at 1.88% higher $33.16 on Friday.

BitMine stock price jumped 19% last week amid the rebound in ETH price. As per Yahoo Finance, the stock has rallied almost 320% year-to-date.

Recently, Fundstrat revealed that BMNR stock remained one of the most traded in the US. The stock recorded an average daily trading volume of $1.7 billion last week.

BitMine (BMNR) Stock Trading Volume | Source: Fundstrat

ETH Price Falls to $2,800

The BitMine stock dip comes as ETH bulls failed to hold above $3,000 level, causing it to drop by 8% over the last 24 hours. The price is trading at $2,811, with a 24-hour low of $2,798 and a high of $3,049.

Trading volume saw a massive 118% increase in the last 24 hours. This indicates that investors are considering buying at dips.

Crypto analyst Ali Martinez turned extremely negative on Ethereum. He suggested using a dollar-cost-averaging strategy to accumulate between $2,200, $1,500, and $1,100.

Ethereum Price in Daily Timeframe | Source: Ali Martinez

The $3,000-$3,100 range remains a crucial resistance zone to break. However, a drop to $2,500-$2,600 could occur if ETH fails to hold the current level.

CoinGlass data showed mixed sentiment in the derivatives market. At the time of writing, the total ETH futures open interest was up only 0.54% in the past hour.

The 24-hour futures dropped more than 4% to $35.28 billion. On the other hand, the 4-Hour ETH futures open interest on CME and Binance tanked more than 1% and 3.50%, respectively.

Source: https://www.thecoinrepublic.com/2025/12/01/breaking-bitmine-immersion-bolsters-ethereum-holdings-to-3-73m-eth-bmnr-stock-tanks-8/

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$3,306.02
$3,306.02$3,306.02
-0.76%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26